heart iconheart icon
Share
Our Company
Johnson & Johnson to Participate in the 26th Annual Credit Suisse Health Care Conference

NEW BRUNSWICK, N.J., Oct. 25, 2017 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the 26th Annual Credit Suisse Health Care Conference on Wednesday, Nov. 8, at The Phoenician in Scottsdale, AZ.  Vanessa Broadhurst, President, Cardiovascular & Metabolism, Janssen Pharmaceuticals and Scott White, President, Immunology, Janssen Pharmaceuticals will represent the Company in a session scheduled at 9:50 a.m. (Mountain Standard Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast and podcast replay will be available approximately two hours after the live webcast.

 (PRNewsfoto/Johnson & Johnson)

 

SOURCE Johnson & Johnson

  • Press Contacts: Ernie Knewitz, (732) 524-6623, (917) 697-2318 (M); Investor Contacts: Joseph Wolk, (732) 524-1142; Lesley Fishman, (732) 524-3922